News
    LuxUrban Hotels Inc. Reports Second Quarter 2024 Financial Results
    Miami, Florida, September 25, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced its financia...

    25 September 2024

    read more...
    LUXHLuxUrban HotelsReal Estate InvestmentNASDAQNews ReleasePRISM DigitalMediaPRISM MarketViewPRISM MediaWireReal Estatestock marketPress Release
    Pharmaceutical
    PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month
    NEW YORK, September 25, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO). In this interview, Dr. Chancellor provides insights into the...

    25 September 2024

    read more...
    LIPOLipella PharmaceuticalsMedical ResearchHEALTHCAREpharmaceuticalNASDAQBiotechnologyNews ReleasePRISM MarketViewstock marketPRISM DigitalMediaPRISM MediaWirePress Release
    News
    LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
    Conference Call and Webcast to be held on September 25, 2024 at 5:00 PM ET

    25 September 2024

    read more...
    LUXHLuxUrban HotelsReal Estate InvestmentNASDAQNews ReleaseStock MarketPRISM DigitalMediaPRISM MarketViewPRISM MediaWireReal EstatePress Release
    News
    Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
    PITTSBURGH, Sept. 24, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced an update on its ongoing m...

    24 September 2024

    read more...
    Lipella PharmaceuticalsLIPOCancer TreatmentNASDAQHEALTHCAREpharmaceuticalBiotechnologyBiopharmaceuticalPress ReleaseNews ReleasePRISM DigitalMediaPRISM MarketViewPRISM MediaWirestock market
    News
    AmpliTech Group Secures Over $700K from Single Spectrum Division Sale, Surpasses $1M in September Bookings
    Hauppauge, NY, September 19, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leader in the design, development, and manufacturing of advanced signal processing components for satellite communications, public and private 5G networks, and other comm...

    19 September 2024

    read more...
    AMPGAmpliTech GroupNASDAQRF ComponentssemiconductorTelecommunicationSatcom5GNews ReleasePRISM MediaWirestock marketpress release
    News
    ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
    Strategic Rebranding Reflects Focus on Neurodegenerative Therapies and Healthy Longevity

    17 September 2024

    read more...
    WENAKLTOpharmaceuticalHEALTHCAREKlotho NeurosciencesNASDAQbiotechpress releaseNews ReleasePRISM DigitalMediastock marketPRISM MarketViewPRISM MediaWire
    News
    PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
    PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

    13 September 2024

    read more...
    News
    AmpliTech Group’s AGTGSS Division Receives Initial Order For Its Midband 5G Radio Networks From Historic University of Edinburgh UK
    Hauppauge, NY, September 12, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including ...

    12 September 2024

    read more...
    AMPGAmpliTech GroupNASDAQSatcomTelecommunication5GnetworkRF Componentssemiconductorpress releaseNews ReleasePRISM DigitalMediaPRISM MarketViewPRISM MediaWirestock market
    Biotechnology
    Aclarion Technology Advances Global Validation with First Nociscan Exams in LIFEHAB Trial on Low Back Pain
    New York, September 10, 2024 - PRISM MediaWire - Aclarion, Inc. (Nasdaq: ACON), a healthcare technology company focused on leveraging biomarkers and augmented intelligence to identify chronic low back pain, announced the completion of the first exams in its ongoing LIFEH...
    read more...
    News
    AmpliTech Group Announces Pricing of $1.0 Million Registered Direct Offering, Priced At-The-Market
    HAUPPAUGE, N.Y., Sept. 9, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications network...
    read more...
    AMPGAmpliTech GroupNASDAQRF ComponentssemiconductorTechnologySatcomTelecommunicationNews ReleasePress ReleasePRISM DigitalMediaPRISM MarketViewPRISM MediaWirestock market
    1
    2
    3
    4
    5
    6
    7
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.